Dr. Reddy's Laboratories, Senores Pharmaceuticals launch Ketorolac Tromethamine Tablets

25 May 2022 Evaluate

Dr. Reddy's Laboratories along with its subsidiaries together and Senores Pharmaceuticals, Inc have launched Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market approved by the U.S. Food and Drug Administration (USFDA).

Ketorolac Tromethamine Tablets USP, 10 mg, is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following intravenous or intramuscular dosing of ketorolac tromethamine, if necessary. Dr. Reddy’s Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1315.00 8.40 (0.64%)
26-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.50
Dr. Reddys Lab 1315.00
Cipla 1357.80
Zydus Lifesciences 938.50
Lupin 2323.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×